Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
01 2Medichem S.A.
02 1AX Pharmaceutical Corp
03 1CARBOGEN AMCIS AG
04 1Catalent Micron Technologies, Inc.
05 1Curia Wisconsin, Inc.
06 2Enaltec Labs Private Limited
07 1FDC Limited
08 1Micro Labs Limited
09 1Nanjing Chemlin Biomedical Science & Technology Co, Ltd.
01 8Nepafenac
02 1Nepafenac (Non-Sterile)
03 1Nepafenac (Sterile)
04 1Nepafenac Sterile
01 1Canada
02 1China
03 4India
04 2Spain
05 1Switzerland
06 2U.S.A
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
NDC Package Code : 53296-0099
Start Marketing Date : 2009-12-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
NDC Package Code : 53296-0118
Start Marketing Date : 2009-12-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 73377-251
Start Marketing Date : 2023-09-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 58567-104
Start Marketing Date : 2014-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69988-0005
Start Marketing Date : 2010-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 64181-0019
Start Marketing Date : 2005-08-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (6kg/6kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42413-0014
Start Marketing Date : 2017-11-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1.375kg/1.375kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42413-0092
Start Marketing Date : 2017-11-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.375kg/.375kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55545-0706
Start Marketing Date : 2024-10-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42571-353
Start Marketing Date : 2019-06-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
A Nepafenac manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nepafenac, including repackagers and relabelers. The FDA regulates Nepafenac manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nepafenac API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nepafenac manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nepafenac supplier is an individual or a company that provides Nepafenac active pharmaceutical ingredient (API) or Nepafenac finished formulations upon request. The Nepafenac suppliers may include Nepafenac API manufacturers, exporters, distributors and traders.
click here to find a list of Nepafenac suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nepafenac as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nepafenac API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nepafenac as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nepafenac and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nepafenac NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nepafenac suppliers with NDC on PharmaCompass.
We have 9 companies offering Nepafenac
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
